Loading...
Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes?
The ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2, represents a potentially major challenge to patients with immune-mediated inflammatory diseases who are treated with immunomodulatory therapies. We report the case of an 18-year-old u...
Na minha lista:
| Udgivet i: | Visc Med |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
S. Karger GmbH
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7316657/ https://ncbi.nlm.nih.gov/pubmed/32999889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000508740 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|